Accreditation:This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the University of Florida College of Medicine. The University of Florida College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit: The University of Florida College of Medicine designates this live activity for a maximum of 21.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Note: The maximum number of 21.75 AMA PRA Category 1 Credits™ includes 15.75 designated for the Symposium, and either 3.0 or 6.00 for a Pre-Symposium Workshop.
Objectives: Upon completion of this course, participants should be able to:
- Review controversies surrounding breast cancer screening
- Identify molecular markers as prognostic and predictive tools
- Outline strategies for preservation of fertility and pregnancy in young women post-treatment
- Assess the contribution of multi-modality breast cancer screening and imaging techniques including mammography, CT, ultrasonography, and MRI
- Present options for management of DCIS for imaging, pathology, surgery, reconstruction, and other issues
- Discuss the complications of breast cancer in elderly patients
- Describe risk assessment tools to identify high-risk patients
- Recognize the challenges and advantages of nipple-sparing mastectomy
- Review concepts in evaluating genomic assays as risk predictors